OpenURL Connection Search

Select item for more details and to access through your institution.

Highly efficient hybridoma generation and screening strategy for anti-PD-1 monoclonal antibody development.
Published in:
Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-20560-6
By:
- Phakham, Tanapati;
- Boonkrai, Chatikorn;
- Wongtangprasert, Tossapon;
- Audomsun, Thittaya;
- Attakitbancha, Chadaporn;
- Saelao, Pijitra;
- Muanwien, Phijitra;
- Sooksai, Sarintip;
- Hirankarn, Nattiya;
- Pisitkun, Trairak
Publication type:
Article
Efficacy of the combination of monoclonal antibodies against the SARS-CoV-2 Beta and Delta variants.
Published in:
PLoS ONE, 2023, v. 17, n. 5, p. 1, doi. 10.1371/journal.pone.0284173
By:
- Boonkrai, Chatikorn;
- Cotrone, Thomas S.;
- Chaisuriyong, Watchadaporn;
- Tantawichien, Terapong;
- Thisyakorn, Usa;
- Fernandez, Stefan;
- Hunsawong, Taweewun;
- Reed, Matthew;
- Wongtangprasert, Tossapon;
- Audomsun, Thittaya;
- Phakham, Tanapati;
- Attakitbancha, Chadaporn;
- Saelao, Pijitra;
- Focht, Dorota;
- Kimbung, Raymond;
- Welin, Martin;
- Malik, Aijaz Ahmad;
- Pisitkun, Trairak;
- Srisawat, Nattachai
Publication type:
Article
Assessment of safety and intranasal neutralizing antibodies of HPMC-based human anti-SARS-CoV-2 IgG1 nasal spray in healthy volunteers.
Published in:
Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-42539-7
By:
- Imsuwansri, Thanarath;
- Jongthitinon, Thitinan;
- Pojdoung, Niramon;
- Meesiripan, Nuntana;
- Sakarin, Siriwan;
- Boonkrai, Chatikorn;
- Wongtangprasert, Tossapon;
- Phakham, Tanapati;
- Audomsun, Thittaya;
- Attakitbancha, Chadaporn;
- Saelao, Pijitra;
- Muanwien, Phijitra;
- Tian, Maoxin Tim;
- Tongchusak, Songsak;
- Sangruji, Bhrus;
- Wannigama, Dhammika Leshan;
- Sawangmake, Chenphop;
- Rodprasert, Watchareewan;
- Le, Quynh Dang;
- Purbantoro, Steven Dwi
Publication type:
Article

Found: 3

Highly efficient hybridoma generation and screening strategy for anti-PD-1 monoclonal antibody development.

Efficacy of the combination of monoclonal antibodies against the SARS-CoV-2 Beta and Delta variants.

Assessment of safety and intranasal neutralizing antibodies of HPMC-based human anti-SARS-CoV-2 IgG1 nasal spray in healthy volunteers.